Global Ischemic Stroke Market Overview:
According to SPER Market Research, the Global Ischemic Stroke Market is estimated to reach USD 13.54 billion by 2032 with a CAGR of 4.24%.
Strokes can also happen when the blood supply to the brain is cut off. Strokes frequently happen when a blood vessel in the brain rupture, allowing haemorrhage to escape. This fracture, or any other sort of obstruction, prevented the blood and oxygen from reaching the brain tissues. Transient ischemic attack (TIA), haemorrhagic stroke, or ischemic stroke are the three main types of strokes that affect everyone in the globe. This procedure uses popular diagnostic tools like echocardiograms, MRIs, CT scans, cerebral angiograms, and blood tests. Treatments for this condition include aspirin, other antiplatelet medications, and anticoagulants.The market for ischemic stroke is being driven by factors such increased health awareness, rising diabetes rates, a rise in tobacco use, and an ageing population. However, the development of new developing technologies for ischemic stroke detection and treatment methods also contributes to the market growth. The maximum amount of blood typically stops abruptly reaching certain parts of the brain, which is how an ischemic stroke usually happens. The region and mechanism of ischemic strokes can be separated. Depending on how they grow within the bodily components, all blood clots inside the body are either thrombotic or embolic.There are expected to be significant growth opportunities in the market for acute ischemic stroke diagnosis and treatment as a result of increased public awareness of stroke and the range of market-available treatments, encouraging government initiatives, and the quickening pace of technological advancements in surgical procedures.The market for the diagnosis and treatment of acute ischemic stroke is expected to grow, but this is expected to be constrained by the high cost of care and the unfavourable reimbursement environment. Additionally, there may be challenges due to the numerous issues associated with product development and manufacturing.
Impact of COVID-19 on the Global Ischemic Stroke Market
According to the Ischemic Stroke market analysis, the virus known as the severity of acute respiratory syndrome of coronavirus 2 that is spread within people is the cause of this condition. Additionally, there has been a slight decline in hospital sectors as a result of the COVID-19 pandemic. It was as a result of individuals becoming afraid of the infection during the lockdown and distance-keeping phase. For health emergencies, a number of nations imposed a rigorous lockdown on their territory. The international trade and business sectors have been suspended for a while. The need for cutting-edge medical equipment has already increased during the lockdown.The COVID-19 has had a direct impact on the global hospital and healthcare industries. Overall, the disease had a very seriously detrimental effect on the market value for ischemic strokes. Investors have suffered a significant loss as a result of the decline in production and manufacturing work. Furthermore, because of several hospital-based therapies for ischemic stroke patients, the major companies in this business are obligated to cut their investment in raw materials and resources. It is also one of the most crucial things to go through at this difficult time. Since every worldwide industry has been severely impacted by this epidemic, most manufacturers aim to satisfy the needs of many industries.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Diagnosis, By Drug Class, By Surgery, By End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | Abott Laboratories, Bayer AG, Boehringer Ingelheim, Boston Scientific Corporation, Cordis Corporation, Covidien plc, GE Healthcare, Genentech, Inc., Jhonson & Jhonson, Koninklijke Philips N.V., Medtronic plc, Merck & Co., Inc., Philips Healthcare, Sanofi, Stryker Corporation
|
Global Ischemic Stroke Market Segmentation:
By Diagnosis: Based on the Diagnosis, Global Ischemic Stroke Market is segmented as; Carotid Ultrasound, Cerebral Angiography, Computed Tomography, Echocardiography, Electrocardiography, Magnetic Resonance Imaging, Others.
By Drug Class: Based on the Drug Class, Global Ischemic Stroke Market is segmented as; Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive, Others.
By Surgery: Based on the Surgery, Global Ischemic Stroke Market is segmented as; Angioplasty, Carotid Endarterectomy, Endovascular Mechanical Thrombectomy.
By End User: Based on the End User, Global Ischemic StrokeMarket is segmented as; Hospitals & Clinic, Medical Institutes, Research Organization, Others.
By Region: Due to rapid technological improvement in the acute ischemic stroke treatment process and supportive government policies, the North American area dominates the acute ischemic stroke diagnosis and treatment market. Because of the rise in ischemic stroke Asia-Pacific is anticipated to develop much faster than the global average.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Ischemic Stroke Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Ischemic Stroke Market, By Diagnosis, 2019-2032 (USD Million)
6.1. Carotid Ultrasound
6.2. Cerebral Ultrasound
6.3. Compound Angiography
6.4. Echocardiography
6.5. Electrocardiography
6.6. Magnetic Resonance Imaging
6.7. Others
7. Global Ischemic Stroke Market, By Drug Class, 2019-2032 (USD Million)
7.1. Tissue Plasminogen Activator
7.2. Anticoagulant
7.3. Antiplatelet
7.4. Antihypertensive
7.5. Others
8. Global Ischemic Stroke Market, By Surgery, 2019-2032 (USD Million)
8.1. Angioplasty
8.2. Carotid Endarterectomy
8.3. Endovascular Mechanical Thrombectomy
9. Global Ischemic Stroke Market, By End User, 2019-2032 (USD Million)
9.1. Hospitals & Clinic
9.2. Medical Institutes
9.3. Research Organization
9.4. Others
10. Global Ischemic Stroke Market, By Region, 2019-2032 (USD Million)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of South America
10.5. Middle East & Africa
10.5.1. Kingdom of Saudi Arabia
10.5.2. United Arab Emirates
10.5.3. Rest of Middle East & Africa
11. Company Profiles
11.1. Abott Laboratories
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Bayer AG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Boehringer Ingelheim
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Boston Scientific Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Cordis Corporation
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Covidien plc
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. GE Healthcare
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Genentech, Inc.
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Jhonson&Jhonson
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Koninklijke Philips N.V.
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Medtronic plc
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Merck & Co. Inc.
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments
11.13. Philips Healthcare
11.13.1. Company details
11.13.2. Financial outlook
11.13.3. Product summary
11.13.4. Recent developments
11.14. Sanofi
11.14.1. Company details
11.14.2. Financial outlook
11.14.3. Product summary
11.14.4. Recent developments
11.15. Stryker Corporation
11.15.1. Company details
11.15.2. Financial outlook
11.15.3. Product summary
11.15.4. Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
